Clinical trial · Observational
ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening
ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening (PEC 24-239)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates among Veterans receiving LCS. ICARE-LCS will use implementation methods to inform national cancer prevention efforts and build infrastructure necessary to support broad implementation of high-impact tobacco dependence treatment (TDT) processes in LCS programs.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Screening | Lung Neoplasm | PROBABILISTIC | 0.70 |
| Tobacco Dependence Treatment | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| External Facilitation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Veterans Participating in Lung Cancer Screening who Smoke
- description
- Veterans participating in lung cancer screening who smoke and are receiving care at participating VA medical centers
- label
- Participating VA Medical Centers
- description
- Seven sites that have agreed to participate in implementation intervention
- interventionNames
- Other: External Facilitation
Primary outcomes (1)
- measure
- Receipt of Combined Tobacco Dependence Treatment
- timeFrame
- Approximately 3 years
- description
- Participation in counseling and pharmacotherapy within 90 days of lung cancer screening referral
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * This is a VAMC based Quality Improvement Partnered Evaluation Initiative. VA sites from around the country that agreed to participate are included. Exclusion Criteria: * N/A
References
Publications (0)
Data not yet available